Skip to main content
Fig. 1 | BMC Medical Research Methodology

Fig. 1

From: Classification of PR-positive and PR-negative subtypes in ER-positive and HER2-negative breast cancers based on pathway scores

Fig. 1

Cell percentage categories of ER and PR expression in HER2- breast cancers from TCGA. The case number of each specific ER and PR expression status was summarized and presented. ER and PR expression were reported either as negative or as the percentage of cells showed positive expression which was subgrouped into 10 categories with a 10 % interval

Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us